Overview
Dr. Susanna Naggie completed her undergraduate degrees in chemical engineering and biochemistry at the University of Maryland, College Park, and her medical education at Johns Hopkins School of Medicine. She conducted her internal medicine and infectious diseases fellowship training at Duke University Medical Center, where she also served as Chief Resident. She joined the faculty in the Duke School of Medicine in 2009. She is a Professor of Medicine and currently holds appointments at the Duke University School of Medicine, at the Duke Clinical Research Institute, and at the Durham Veterans Affairs Medical Center. Dr. Naggie is a clinical investigator with a focus in clinical trials in infectious diseases and translational research in HIV and liver disease. She is a standing member of the DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents and the CDC/NIH/IDSA-HIVMA Opportunistic Infections Guideline. She is the Vice Dean for Clinical and Translational Research and Director for the Duke Clinical and Translational Sciences Institute.
Current Appointments & Affiliations
In the News
View All News
Recent Publications
Metformin Therapy for Patients With COVID-19 Without Obesity-Reply.
Journal Article JAMA Intern Med · December 29, 2025 Full text Link to item CiteTake It Off the Back Burner-Missed Opportunities to Treat Hepatitis C Virus Inpatients.
Journal Article Clin Infect Dis · December 24, 2025 Full text Link to item CiteThe association of steatotic liver disease with cardiometabolic criteria and cardiovascular disease risk in a large cohort of people living with human immunodeficiency virus.
Journal Article Am J Prev Cardiol · December 2025 BACKGROUND & AIMS: Steatotic liver disease (SLD), both metabolic dysfunction-associated liver disease (MASLD) without or with alcohol-associated liver disease (MetALD), is common in people with HIV (PWH) and associated with increased risk of cardiovascular ... Full text Link to item CiteRecent Grants
1/3 CTSA UM1 at Duke University
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2025 - 2032Combating Related Epidemics in HCV through Simplified Testing and Treatment (CREST). A cluster randomized trial of point-of-care hepatitis C testing and treatment among key populations
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2025 - 2030Interdisciplinary Research Training Program in AIDS
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2010 - 2030View All Grants